SOFIE Biosciences Inc. (SOFIE) concludes $27.4m Series C Financing
Dulles, VA, November 4, 2020 – SOFIE, whose vision is to improve patient outcomes […]
Dulles, VA, November 4, 2020 – SOFIE, whose vision is to improve patient outcomes […]
Article available for purchase […]
“This FDA approval signals another important advancement in the evaluation of Alzheimer’s Disease. With […]